Skip to main content
Clinical Trials/ChiCTR2200057053
ChiCTR2200057053
Not yet recruiting
Not Applicable

糖化血红蛋白对非心脏手术患者术后急性肾损伤的预测价值

非资助项目1 site in 1 countryStarted: March 1, 2022Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
非资助项目
Locations
1
Primary Endpoint
血清肌酐

Overview

Brief Summary

探索术前 HbA1c 对非心脏手术病人术后 AKI 的预测价值

Study Design

Study Type
诊断试验
Primary Purpose
连续入组

Eligibility Criteria

Ages
18 to — (—)
Sex
All

Inclusion Criteria

  • 具有术前 HbA1c、肌酐和术后肌酐测量值的成年病人。

Exclusion Criteria

  • 心脏手术病人、移植手术、泌尿外科手术;
  • EGFR<15 ml-1 1.73m -2;
  • 麻醉前收缩压<90mmHg。

Outcomes

Primary Outcomes

血清肌酐

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
非资助项目

Study Sites (1)

Loading locations...

Similar Trials